Filing Details
- Accession Number:
- 0000895419-10-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-04-23 13:00:00
- Reporting Period:
- 2010-04-22
- Filing Date:
- 2010-04-23
- Accepted Time:
- 2010-04-23 15:45:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 895419 | Cree Inc | CREE | Semiconductors & Related Devices (3674) | 561572719 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1182185 | W John Palmour | C/O Cree, Inc. 4600 Silicon Drive Durham NC 27703 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-04-22 | 70,000 | $71.53 | 394,331 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-04-22 | 15,000 | $74.73 | 379,331 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-22 | 23,000 | $75.86 | 356,331 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-04-22 | 32,000 | $76.59 | 324,331 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | NONQUALIFIED STOCK OPTION (RIGHT TO BUY) | Disposition | 2010-04-22 | 70,000 | $0.00 | 70,000 | $71.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2001-07-03 | 2010-07-03 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Palmour on December 4, 2009.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $74.25 to $75.2401, inclusive. Dr. Palmour undertakes to provide to Cree, Inc., any security holder of Cree, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $75.2801 to $76.25, inclusive. Dr. Palmour undertakes to provide to Cree, Inc., any security holder of Cree, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $76.40 to $76.75, inclusive. Dr. Palmour undertakes to provide to Cree, Inc., any security holder of Cree, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Of the 324,311 shares reported, 284,331 shares are held directly by Dr. Palmour and 40,000 shares are held indirectly by Dr. Palmour's spouse.
- Option vested as to 10,000 shares on July 3, 2001, as to 20,000 shares on July 3, 2002 and as to 40,000 shares on July 3, 2003.
Billionaire Hedge Funds
